| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.099 | 0.08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.096 | 0.08 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |